One of the few bright spots in Boston’s life-science lab space market this year has dimmed.

Boston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, ...

Ginkgo Bioworks reported mixed Q3 results, with a $45 million one-time revenue boost masking underlying revenue growth issues ...

合成生物学领先公司Ginkgo Bioworks Holdings Inc.（纽约证券交易所代码：DNA）公布了2024年第三季度财务业绩，强调了战略进展和显著的成本削减。首席执行官Jason Kelly和首席财务官Mark Dmytruk强调公司旨在实现调整后EBITDA收支平衡，同时保持6.16亿美元的强劲现金状况，且无银行债务。 尽管细胞工程收入下降20%，但Ginkgo与默沙东集团达成了9 ...

Ginkgo Bioworks advances collaboration with Merck to improve biologics manufacturing; Ginkgo to receive a research milestone payment of $9 million: Boston, Massachusetts Thursday, ...

Ginkgo Bioworks is headquartered at 27 Drydock Avenue in Boston's Seaport. Ginkgo has canceled its planned move into a ...

Ginkgo Bioworks Holdings, Inc. ( (DNA)) has released its Q3 earnings. Here is a breakdown of the information Ginkgo Bioworks Holdings, Inc. presented to its investors. Ginkgo Bioworks Holdings, Inc.

Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...

根据Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)最近披露的交易信息，首席会计官Steven P. Coen报告出售了公司的A类普通股。11月4日，Coen以每股7.576美元的价格出售了333股，总价值约为2,522美元。根据文件记录，这次出售是为了支付与限制性股票单位解锁相关的税收预扣义务。

Ginkgo Bioworks reported a significant revenue increase of 61% in Q3 2024, primarily due to a $45 million non-cash deferred revenue release, despite a shift towards larger customers impacting cell ...

Boston-based Ginkgo Bioworks has canceled plans to move into a 250K SF lab data center and will exit two Cambridge locations ...